AntineoplasticsMyelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92610-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[41] AntineoplasticsMyelosuppression: 2 case reports
Reactions Weekly, 2020, 1830 (1) : 49 - 49
[42] AntineoplasticsMyelosuppression: 13 case reports
Reactions Weekly, 2011, 1363 (1) : 8 - 9
[43] AntineoplasticsMyelosuppression, drug-induced liver injury and lack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 37 - 37
[44] AntineoplasticsMyelosuppression and infections: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 67 - 67
[45] AntineoplasticsMyelosuppression and tubulopathy: 7 case reports
Reactions Weekly, 2016, 1620 (1) : 29 - 29
[46] AntineoplasticsMyelosuppression and haematological toxicity: 5 case reports
Reactions Weekly, 2018, 1703 (1) : 42 - 42
[47] AntineoplasticsMyelosuppression, nausea and vomiting: 8 case reports
Reactions Weekly, 2021, 1871 (1) : 54 - 54
[48] AntineoplasticsMyelosuppression and renal insufficiency: 5 case reports
Reactions Weekly, 2019, 1752 (1) : 39 - 39
[49] AntineoplasticsMyelosuppression and lack of efficacy: 8 case reports
Reactions Weekly, 2022, 1904 (1) : 57 - 57
[50] AntineoplasticsMyelosuppression, right lower extremity skin ulcerations secondary to off-label use: case report
Reactions Weekly, 2021, 1841 (1) : 34 - 34

← 1 2 3 4 5 →